{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:33:11Z","timestamp":1790386391866,"version":"4.1.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/bjd.16348","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T02:17:49Z","timestamp":1516069069000},"page":"1220-1221","source":"Crossref","is-referenced-by-count":28,"title":["Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with <i>Demodex<\/i>\n and increased interleukin-17 levels?: reply from the authors"],"prefix":"10.1093","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-6993","authenticated-orcid":false,"given":"M.","family":"de Bruin-Weller","sequence":"first","affiliation":[{"name":"University Medical Center Utrecht; Heidelberglaan 100; 3508 GA Utrecht the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.H.","family":"Graham","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc.; Tarrytown NY U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pirozzi","sequence":"additional","affiliation":[{"name":"Sanofi; Bridgewater NJ U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Shumel","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc.; Tarrytown NY U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"10.1111\/bjd.16348-BIB0001|bjd16348-cit-0001","article-title":"Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAF\u00c9)","author":"Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16348-BIB0002|bjd16348-cit-0002","first-page":"1090","article-title":"Comment on: two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"376","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16348-BIB0003|bjd16348-cit-0003","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2017.03.003","article-title":"Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis","volume":"77","author":"Thyssen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16348-BIB0004|bjd16348-cit-0004","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/bjd.16348-BIB0005|bjd16348-cit-0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","article-title":"Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis","volume":"134","author":"Hamilton","year":"2014","journal-title":"J Allergy Clin Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16348","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16348\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:39:11Z","timestamp":1676381951000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/5\/1220\/6753079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16348","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,2]]}}}